Hyve Solutions Corporation, a wholly owned subsidiary of TD SYNNEX Corporation (NYSE:SNX) and a leading provider of hyperscale digital infrastructures, today announced the integration of Intel® Xeon® 6 processors into Hyve-designed motherboards and systems. This collaboration with Intel marks a significant step forward in meeting the diverse performance and efficiency requirements of modern computing environments, from high-performance AI applications to exceptional efficiency and cloud scalability.
Finch Therapeutics Announces Clinical Collaboration In Ulcerative Colitis With Brigham And Women’s Hospital And Updates To University Of Minnesota License Agreement
Finch Therapeutics Group, Inc. ("Finch", "Finch Therapeutics" or the "Company") (NASDAQ:FNCH), a microbiome technology company with a portfolio of intellectual property and microbiome
